Largest Rare Variant–Lipid Association Study Finds Heart Disease Targets
The findings could accelerate the development of precision medicines for dyslipidemia and improve the diagnosis of inherited lipid disorders such as familial hy...
The findings could accelerate the development of precision medicines for dyslipidemia and improve the diagnosis of inherited lipid disorders such as familial hypercholesterolemia. The post Largest Rare Variant–Lipid Association Study Finds Heart Disease Targets appeared first on Inside Precision Medicine .